AI-generated summary
The authors studied mdx mice, an animal model of Duchenne muscular dystrophy, given photobiomodulation therapy at three doses over 14 weeks. They report that the 10 J dose improved functional performance and that the 3 and 10 J doses increased dystrophin gene and protein expression compared with placebo controls. As an animal study, these findings may not apply directly to people.
- Who or what was studied
- mdx mice (animal model of Duchenne muscular dystrophy)
- Wavelengths
- 905, 875, 640 nm
- Limits stated in the abstract
- The study was conducted in mice, so the results may not translate to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 905nm, 875nm, 640nm
- Total energy
- 1 J, 3 J, 10 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Dose, Low-level laser therapy, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.